- Nautilus Biotechnology Inc NAUT shares are trading higher during mid-day trading on Thursday following a CNBC report that Amazon.com Inc AMZN held around $15 million stake in the company at the end of Q2.
- The $14.7 million investment was disclosed in a recent Amazon SEC Form 13F filing.
- Nautilus just went public in early June after a merger with SPAC Arya Sciences Acquisition III.
- Nautilus has a single-molecule protein analysis platform for quantifying the human proteome to aid biomedical research and drug discovery.
- Price Action: NAUT shares are up 13.8% at $8.55 during the market session on the last check Thursday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In: BiotechLong IdeasM&ANewsHealth CareSmall CapMoversTrading IdeasGeneralBriefswhy it's moving
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
